Labeler
Sandoz Inc NDC Codes
Sandoz Inc lists 440 finished drug products in the FDA NDC Directory under NDC labeler codes 0781, 61314.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Dexmethylphenidate Hydrochloride Extended-Release, Lisdexamfetamine dimesylate, Enoxaparin Sodium Injection,USP, Hyrimoz, Pomalidomide, Adalimumab, Bumetanide, Sitagliptin Phosphate, Iron Sucrose, Pyzchiva, Cyclophosphamide, Pirfenidone, Pemetrexed, Lidocaine Hydrochloride, Sugammadex
- Active ingredients
- Dexmethylphenidate hydrochloride, Adalimumab, Lisdexamfetamine dimesylate, Enoxaparin sodium, Sitagliptin phosphate, Pomalidomide, Bumetanide, Iron sucrose, Ustekinumab, Cyclophosphamide, Pirfenidone, Pemetrexed disodium
- NDC labeler codes
- 0781, 61314
- Strengths (from the 100 most recently listed products)
- Sitagliptin phosphate 50 mg/1; Adalimumab 10 mg/.1mL; Adalimumab 80 mg/.8mL; Adalimumab 20 mg/.2mL; Fulvestrant 50 mg/mL; Adalimumab 40 mg/.4mL; Pirfenidone 267 mg/1; Aflibercept 2 mg/.05mL; Lidocaine hydrochloride 10 mg/mL; Lidocaine hydrochloride 20 mg/mL; Dexmethylphenidate hydrochloride 25 mg/1; Dexmethylphenidate hydrochloride 30 mg/1; Dexmethylphenidate hydrochloride 35 mg/1; Dexmethylphenidate hydrochloride 40 mg/1; Bumetanide .5 mg/1; Bumetanide 1 mg/1; Bumetanide 2 mg/1; Dexmethylphenidate hydrochloride 15 mg/1; Dexmethylphenidate hydrochloride 5 mg/1; Dexmethylphenidate hydrochloride 10 mg/1
- Dosage forms
- Injection, Solution, Capsule, Tablet, Film coated, Injection, Capsule, Extended release, Tablet, Injection, Solution, Concentrate, Solution/ drops, Kit, Injection, Powder, Lyophilized, For solution, Concentrate, Suspension/ drops, Injection, Powder, For solution, Injection, Powder, Lyophilized, For suspension, Aerosol, Metered
- Routes
- Oral, Intravenous, Subcutaneous, Intravitreal, Ophthalmic, Epidural, Infiltration, Intracaudal, Perineural, Intramuscular, Parenteral, Respiratory (Inhalation)
- Drug classes (FDA established)
- Central Nervous System Stimulant, Tumor Necrosis Factor Blocker, Low Molecular Weight Heparin, Parenteral Iron Replacement, Dipeptidyl Peptidase 4 Inhibitor, Thalidomide Analog, Phosphate Binder, Vascular Endothelial Growth Factor Inhibitor, Loop Diuretic, Interleukin-12 Antagonist, Interleukin-23 Antagonist, Pyridone, Folate Analog Metabolic Inhibitor, Amide Local Anesthetic, Antiarrhythmic, Aminosalicylate, Biguanide, Sodium-Glucose Cotransporter 2 Inhibitor, Kinase Inhibitor, Microtubule Inhibitor, Serotonin-4 Receptor Agonist, RANK Ligand Inhibitor, alpha-Adrenergic Agonist, Estrogen Receptor Antagonist, Phenothiazine, Macrolide Antibacterial, Corticosteroid, Purine Antimetabolite, Proton Pump Inhibitor, Integrin Receptor Antagonist, Endothelin Receptor Antagonist, Barbiturate, Methylxanthine, Nonsteroidal Anti-inflammatory Drug, Platelet Aggregation Inhibitor, Nucleoside Metabolic Inhibitor, Prostaglandin Analog, beta-Adrenergic Blocker, Penicillin-class Antibacterial, beta Lactamase Inhibitor, beta2-Adrenergic Agonist
- HCPCS / J-code
- J0178 — Injection, aflibercept, 1 mg, J1756 — Injection, iron sucrose, 1 mg, J0897 — Injection, denosumab, 1 mg, J0135 — Injection, adalimumab, 20 mg, J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mg, J2778 — Injection, ranibizumab, 0.1 mg
- Package NDCs
- 141 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Prucalopride | Prucalopride succinate 2 mg/1 | Tablet, Film coatedOral | 0781-8159 | 00781-8159-31 | — |
| Jubbontidenosumab | Denosumab 60 mg/mL | InjectionSubcutaneous | 61314-240 | 61314-0240-63 | J0897 |
| Wyostdenosumab | Denosumab 120 mg/1.7mL | InjectionSubcutaneous | 61314-228 | 61314-0228-94 | J0897 |
| Adalimumabadalimumab-adaz | Adalimumab 10 mg/.1mL | Injection, SolutionSubcutaneous | 61314-391 | 61314-0391-64 | J0135 |
| Pyzchivaustekinumab-ttwe | Ustekinumab 45 mg/.5mL | Injection, SolutionSubcutaneous | 61314-651 | 61314-0651-0161314-0651-94 | J3357 |
| Pyzchivaustekinumab-ttwe | Ustekinumab 90 mg/mL | Injection, SolutionSubcutaneous | 61314-652 | 61314-0652-01 | J3357 |
| Pyzchivaustekinumab-ttwe | Ustekinumab 130 mg/26mL | Injection, SolutionIntravenous | 61314-654 | 61314-0654-94 | — |
| Edaravone | Edaravone 30 mg/100mL | InjectionIntravenous | 0781-3527 | 00781-3527-20 | — |
| Adalimumabadalimumab-adaz | Adalimumab 80 mg/.8mL | Injection, SolutionSubcutaneous | 61314-325 | 61314-0325-20 | J0135 |
| Cimerliranibizumab-eqrn | Ranibizumab .5 mg/.05mL | Injection, SolutionIntravitreal | 61314-625 | 61314-0625-94 | J2778 |
| Cimerliranibizumab-eqrn | Ranibizumab .3 mg/.05mL | Injection, SolutionIntravitreal | 61314-624 | 61314-0624-94 | J2778 |
| Adalimumabadalimumab-adaz | Adalimumab 20 mg/.2mL | Injection, SolutionSubcutaneous | 61314-332 | 61314-0332-64 | J0135 |
| Paclitaxel | Paclitaxel 100 mg/20mL | Injection, Powder, Lyophilized, For suspensionIntravenous | 0781-3531 | 00781-3531-91 | — |
| Butalbital, aspirin, and caffeine | Butalbital 50 mg/1 + 2 more ingredients | CapsuleOral | 0781-2270 | 00781-2270-01 | — |
| Azacitidine | Azacitidine 100 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous, Subcutaneous | 0781-3491 | 00781-3491-94 | — |
| Cyclophosphamide | Cyclophosphamide 1000 mg/10mL | Injection, Solution, ConcentrateIntravenous | 0781-3529 | 00781-3529-10 | — |
| Cyclophosphamide | Cyclophosphamide 2000 mg/20mL | Injection, Solution, ConcentrateIntravenous | 0781-3530 | 00781-3530-10 | — |
| Cyclophosphamide | Cyclophosphamide 500 mg/5mL | Injection, Solution, ConcentrateIntravenous | 0781-3528 | 00781-3528-10 | — |
| Brimonidinebrimonidine tartrate | Brimonidine tartrate 1 mg/mL | Solution/ dropsOphthalmic | 0781-7177 | 00781-7177-7000781-7177-7500781-7177-85 | — |
| Fulvestrant | Fulvestrant 50 mg/mL | InjectionIntramuscular | 0781-3532 | 00781-3532-12 | — |
| Fulvestrant | Fulvestrant 50 mg/mL | InjectionIntramuscular | 0781-9055 | 00781-9055-12 | — |
| Adalimumabadalimumab-adaz | Adalimumab 40 mg/.4mL | Injection, SolutionSubcutaneous | 61314-327 | 61314-0327-2061314-0327-64 | J0135 |
| Hyrimozadalimumab-adaz | Adalimumab 80 mg/.8mL | Injection, SolutionSubcutaneous | 61314-454 | 61314-0454-2061314-0454-3661314-0454-68 | J0135 |
| Hyrimozadalimumab-adaz | Adalimumab 40 mg/.4mL | Injection, SolutionSubcutaneous | 61314-473 | 61314-0473-2061314-0473-6461314-0473-92 | J0135 |
| Hyrimozadalimumab-adaz | Adalimumab 20 mg/.2mL | Injection, SolutionSubcutaneous | 61314-476 | 61314-0476-64 | J0135 |
| Hyrimozadalimumab-adaz | — | Kit | 61314-531 | 61314-0531-64 | — |
| Hyrimozadalimumab-adaz | Adalimumab 10 mg/.1mL | Injection, SolutionSubcutaneous | 61314-509 | 61314-0509-64 | J0135 |
| Hyrimozadalimumab-adaz | — | Kit | 61314-517 | 61314-0517-36 | — |
| Chlorpromazine Hydrochloride | Chlorpromazine hydrochloride 100 mg/mL | ConcentrateOral | 0781-4028 | 00781-4028-22 | — |
| Chlorpromazine Hydrochloride | Chlorpromazine hydrochloride 30 mg/mL | ConcentrateOral | 0781-4027 | 00781-4027-53 | — |
| Enoxaparin Sodium Injection,USP | Enoxaparin sodium 40 mg/.4mL | Injection, SolutionSubcutaneous | 0781-3482 | 00781-3482-63 | — |
| Enoxaparin Sodium Injection,USP | Enoxaparin sodium 60 mg/.6mL | Injection, SolutionSubcutaneous | 0781-3488 | 00781-3488-63 | — |
| Enoxaparin Sodium Injection,USP | Enoxaparin sodium 80 mg/.8mL | Injection, SolutionSubcutaneous | 0781-3502 | 00781-3502-63 | — |
| Enoxaparin Sodium Injection,USP | Enoxaparin sodium 100 mg/mL | Injection, SolutionSubcutaneous | 0781-3505 | 00781-3505-63 | — |
| Enoxaparin Sodium Injection,USP | Enoxaparin sodium 120 mg/.8mL | Injection, SolutionSubcutaneous | 0781-3510 | 00781-3510-63 | — |
| Enoxaparin Sodium Injection,USP | Enoxaparin sodium 150 mg/mL | Injection, SolutionSubcutaneous | 0781-3513 | 00781-3513-63 | — |
| Enoxaparin Sodium Injection,USP | Enoxaparin sodium 30 mg/.3mL | Injection, SolutionSubcutaneous | 0781-3460 | 00781-3460-63 | — |
| Pirfenidone | Pirfenidone 267 mg/1 | CapsuleOral | 0781-2158 | 00781-2158-32 | — |
| Tafluprost | Tafluprost .0045 mg/.3mL | Solution/ dropsOphthalmic | 0781-6184 | 00781-6184-87 | — |
| Pemetrexedpemetrexed disodium | Pemetrexed disodium 100 mg/4mL | Injection, SolutionIntravenous | 0781-3518 | 00781-3518-76 | — |
| Pemetrexedpemetrexed disodium | Pemetrexed disodium 500 mg/20mL | Injection, SolutionIntravenous | 0781-3519 | 00781-3519-90 | — |
| Pemetrexedpemetrexed disodium | Pemetrexed disodium 1000 mg/40mL | Injection, SolutionIntravenous | 0781-3520 | — | — |
| Arsenic Trioxide | Arsenic trioxide 2 mg/mL | Injection, SolutionIntravenous | 0781-3498 | 00781-3498-9400781-3498-95 | — |
| Pirfenidone | Pirfenidone 267 mg/1 | Tablet, Film coatedOral | 0781-8085 | 00781-8085-32 | — |
| Pirfenidone | Pirfenidone 801 mg/1 | Tablet, Film coatedOral | 0781-8086 | 00781-8086-92 | — |
| Brimonidine Tartrate and Timolol Maleate | Brimonidine tartrate 2 mg/mL; Timolol maleate 5 mg/mL | Solution/ dropsOphthalmic | 0781-7186 | 00781-7186-7000781-7186-7500781-7186-85 | — |
| Piperacillin and Tazobactam | Piperacillin sodium 36 g/250mL; Tazobactam sodium 4.5 g/250mL | Injection, Powder, Lyophilized, For solutionIntravenous, Parenteral | 0781-3180 | 00781-3180-94 | — |
| Ferumoxytol | Ferumoxytol non-stoichiometric magnetite 510 mg/17mL | InjectionIntravenous | 0781-3154 | 00781-3154-0100781-3154-95 | — |
| Carmustine | — | Kit | 0781-3474 | 00781-3474-32 | — |
| Albuterol Sulfate | Albuterol sulfate 108 ug/1 | Aerosol, MeteredRespiratory (Inhalation) | 0781-7296 | 00781-7296-85 | — |
Sandoz Inc: common questions
- What is Sandoz Inc's NDC labeler code?
- 0781, 61314. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Sandoz Inc?
- Med-Code's HCPCS directory matches J0178, J1756, J0897, J0135, J3357, J2778 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.